PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1683527
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1683527
The UK Ultrasound Devices Market is expected to register a CAGR of 4.85% during the forecast period.
COVID-19 significantly impacted the ultrasound devices market in the United Kingdom, as the workflow of various departments, such as obstetrics and gynecology, among others, were severely impacted during the pandemic. For instance, according to an article published by the Journal of Medical Imaging and Radiation Sciences in December 2022, the COVID-19 pandemic expectedly had a significant impact on the provision of obstetric ultrasound services in the United Kingdom, which ultimately led to the publication of new guidance and requirement for individual departmental risk assessments in the country. Thus, such factors affected the growth of the studied market during the pandemic. However, as the pandemic has subsided, the United Kingdom ultrasound devices market is expected to have proper growth during the forecast period of the study.
Ultrasound devices are used in imaging procedures to diagnose various diseases, such as nephrological, musculoskeletal, urological, and cardiovascular diseases. The rising prevalence of such conditions in the country is anticipated to boost the growth of the ultrasound devices market in the United Kingdom throughout the study's projected period. For instance, according to the data published by the British Heart Foundation in 2022, an estimated 0.99 million inpatient admissions in the United Kingdom in 2021 were due to heart and circulatory diseases, of which 0.25 million were due to coronary artery disease. Moreover, according to the data updated by the National Health Service (NHS) in November 2022, kidney stones are said to be quite common in the United Kingdom, with more than 1 in 10 people affected every year. Thus, the high prevalence of such chronic diseases in the country is expected to boost the growth of the studied market.
Also, ultrasound devices are widely used for fetus monitoring during the gestational period, so the high pregnancy rate in the country is also expected to improve the adoption of these devices during the forecast period. For instance, according to the data updated by NHS in June 2022, an estimated 56,910 women with an antenatal booking appointment were reported in the United Kingdom in January 2022, of which 53% were within the first ten weeks of pregnancy. Thus, the high rate of antenatal booking in the United Kingdom is expected to increase the adoption of ultrasound procedures for fetus monitoring procedures.
Moreover, the rising developments by market players and other private and government organizations, such as partnerships and agreements, are also expected to bolster the market growth, as this is expected to improve access to technologically advanced products. For instance, in November 2021, the Manchester University NHS Foundation Trust (MFT) installed a series of new C-arms, interventional imaging, mobile X-ray, and ultrasound equipment. The upgrades were a part of over 350 installations scheduled over a 15-year partnership with Siemens Healthineers. Thus, such developments are expected to increase the usage of ultrasound devices in the country, thus improving market growth.
Thus, the factors such as the rising prevalence of chronic diseases, e.g., nephrological and cardiovascular disorders, and the increasing developments by market players and other private and government organizations are expected to boost the market growth during the forecast period of the study. However, stringent regulations are expected to hinder market growth.
2D ultrasound is one of the most common forms of ultrasound. It creates a black-and-white image of the baby, shows its skeletal structure during fetus monitoring, and makes the internal organs visible. Moreover, 2D ultrasound is also helpful in detecting diseases such as tumors, polyps, or cysts in a major organ. The 2D ultrasound imaging segment is expected to hold a significant market share due to the high availability of these devices. Also, factors such as increasing cancer prevalence, the high birthrate in the country, and initiatives by key players are expected to increase segment growth. For instance, according to an article published by JAMA Network Open in December 2022, an estimated 57,215 people were living with breast cancer in England in 2021, of which 7,580 were newly diagnosed 2021. Hence, the high prevalence of such diseases is expected to increase the usage of 2D ultrasound systems in the United Kingdom.
Moreover, according to the data updated by the Office for National Statistics in August 2022, the total fertility rate in England and Wales increased for the first time in a decade during 2021. The most significant rise was observed among women aged between 35 and 39. The source also stated that the general fertility rate, the number of live births per 1,000 women, also increased in 2021 to 55.8 births per 1,000 women, compared with 55.1 the year before. Thus, the rising fertility rate in the United Kingdom is expected to increase the adoption of 2D ultrasound imaging devices for proper fetus monitoring procedures.
Hence, due to the above factors about 2D ultrasound imaging systems, the studied segment is expected to experience market growth in the country.
Ultrasound devices are widely used to diagnose diseases related to heart functions and valves. Thus, the increasing prevalence of such conditions in the United Kingdom, coupled with the rising geriatric population in the country, is expected to boost the segment growth in the country. For instance, according to the data published by the British Heart Foundation in 2022, an estimated 1.63 million inpatient episodes in the United Kingdom in 2021 were due to heart and circulatory diseases, out of which 0.39 million were due to coronary artery disease. Thus, the high prevalence of such chronic diseases in the country is expected to boost the growth of the studied market. It is expected to increase the usage of ultrasound devices for proper disease diagnosis.
Moreover, a large geriatric population in the country is also expected to boost market growth as cardiovascular diseases such as coronary heart disease are primarily diagnosed in older people. For instance, according to the data updated by the United Nations Population Fund Dashboard in 2022, an estimated 19% of the total population in the United Kingdom was aged 65 years or older in 2022.
Thus, the factors mentioned above, such as the high prevalence of cardiovascular diseases in the United Kingdom and the rising geriatric population, are expected to enhance segment growth.
The United Kingdom ultrasound devices market is highly competitive and consists of several major players. Some of the key companies in the market are Canon Medical Systems Corporation, GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, and Koninklijke Philips NV, among others.